Oct 23 (Reuters) - Elekta AB (publ) EKTAb.ST :
* EXPANDS MARKET AND TREATMENT APPLICATION OF BRACHYTHERAPY WITH ACQUISITION OF ICAD, INC.’S
XOFT
BUSINESS
* AIMS TO COMPLETE TRANSACTION DURING Q2 OF ELEKTA'S FISCAL YEAR 2023/24
* DEAL THROUGH ASSET ACQUISITION
* WITH ACQUISITION WILL BE ABLE TO OFFER ELECTRONIC BRACHYTHERAPY TECHNOLOGY, PROVIDE
EXPANDED
RANGE OF CANCER TREATMENT OPTIONS
Source text for Eikon: ID:nMFN3NhrDg
Further company coverage: EKTAb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))